Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

A reduction in prescriptions of sleep drugs for older adults is associated with substantial health and economic benefits, according to an October study published in The Lancet Regional Health – ...

Millions of older Americans suffering from insomnia regularly use prescription sleep medications, despite the risk of serious side effects-such as falls, broken bones, cognitive impairment and ...

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

Benefits include reduction in falls and cognitive impairment and improvements in life expectancy, quality of life. HealthDay News — Reducing future use of sleep medications could help older adults ...

When you want to sleep, you go to bed, lie down, and close your eyes. Simple, right? Well, not quite. For many, this is a luxury they cannot afford. Global data shows that one in every six adults ...

The Food and Drug Administration approved Zepbound as the first prescription medicine to treat sleep apnea on Friday—marking a significant win for the drug company Eli Lilly, which had Zepbound ...

UNIVERSITY PARK, Pa. — Insomnia is a significant health and quality of life concern for older adults, with up to half of all adults over the age of 65 experiencing insomnia symptoms. In a new study, ...

A new study from Penn State University found that older adults who experience symptoms of insomnia and/or use sleep medications face a substantially higher risk of developing disabilities that affect ...

GABA is a neurotransmitter that reduces brain activity, but it's also a supplement that could help with sleep.